Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

TRAIL R2/DR5/TNFRSF10B Protein, Human, Recombinant

(Synonyms: ZTNFR9, Tumor necrosis factor receptor superfamily member 10B, TRICKB, TRICK2B, TRICK2A, TRICK2, TRAIL-R2, TRAILR2, TRAIL receptor 2, TNFRSF10B, TNF-related apoptosis-inducing ligand receptor 2, KILLER/DR5, KILLER, DR5, Death receptor 5, CD262) Copy Product Info

Synonyms: ZTNFR9, Tumor necrosis factor receptor superfamily member 10B, TRICKB, TRICK2B, TRICK2A, TRICK2, TRAIL-R2, TRAILR2, TRAIL receptor 2, TNFRSF10B, TNF-related apoptosis-inducing ligand receptor 2, KILLER/DR5, KILLER, DR5, Death receptor 5, CD262

Catalog No. TMPS-00158 Copy Product Info
TRAIL R2/DR5/TNFRSF10B Protein, Human, Recombinant is expressed in E. coli. The accession number is O14763.
TRAIL R2/DR5/TNFRSF10B Protein, Human, Recombinant
TargetMol | Customer service
Customer service consultation
Pack SizePriceUSA StockGlobal StockQuantity
5 µg$917-10 days7-10 days
10 µg$1477-10 days7-10 days
20 µg$2137-10 days7-10 days
50 µg$3567-10 days7-10 days
100 µg$5537-10 days7-10 days
200 µg$8667-10 days7-10 days
500 µg$1,5607-10 days7-10 days
1 mg$2,4607-10 days7-10 days
For In stock only · Estimated delivery: USA Stock (1-2 days) Global Stock (5-7 days)
Add to Cart
Add to Quotation
For research use only—not for human use. No sales to individuals. Use as intended only.
Questions
TargetMol
View More

Product Introduction

Bioactivity
Bioactivity
Fully biologically active when compared to standard. rHusTRAIL-R2 reduced the production of LPS-induced TNF by its ability to neutralize endogenous TRAIL in fresh human PBMC. In this assay, endogenous TRAIL is induced during a 24 hour exposure to LPS (10 ng/ml) but in the presence of rHusTRAIL-R2, TRAIL-induced TNF is suppressed.
Description
TRAIL R2/DR5/TNFRSF10B Protein, Human, Recombinant is expressed in E. coli. The accession number is O14763.
Species
Human
Expression System
E. coli
TagTag Free
Accession NumberO14763
ConstructionGlu52-Ser183
Protein Purity
> 97% as determined by SDS-PAGE; > 97% as determined by HPLC
Endotoxin< 1.0 EU/μg of the protein as determined by the LAL method.
FormulationLyophilized from a 0.2 μm filtered solution in PBS, pH 7.4.
ReconstitutionIt is recommended that this vial be briefly centrifuged prior to opening to bring the contents to the bottom. Reconstitute the lyophilized powder in sterile distilled water or aqueous buffer containing 0.1 % BSA to a concentration of 0.1-1.0 mg/ml.
SynonymsZTNFR9, Tumor necrosis factor receptor superfamily member 10B, TRICKB, TRICK2B, TRICK2A, TRICK2, TRAIL-R2, TRAILR2, TRAIL receptor 2, TNFRSF10B, TNF-related apoptosis-inducing ligand receptor 2, KILLER/DR5, KILLER, DR5, Death receptor 5, CD262
Research Background
Tumor necrosis factor-related apoptosis-inducing ligand Receptor 2 (TRAIL-R2) is a cell-surface receptor involved in tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced cell-death signaling.1 The death ligand TRAIL bears high potential as a new anticancer agent, as binding to the death receptors TRAIL-R1 or TRAIL-R2 triggers apoptosis in most cancer cells.2 TRAIL-R2 has been shown to be associated with a decrease in the survival rates of breast cancer patients.
Chemical Properties
Molecular Weight14.8 kDa (Predicted)
Storage & Solubility Information
ShippingIn general, lyophilized powders are shipped with blue ice, while solutions are shipped with dry ice.
StorageUpon receiving, this product remains stable for up to 6 months at -70°C or -20°C. Upon reconstitution, the product should be stable for up to 1 week at 4°C or up to 3 months at -20°C. Avoid repeated freeze-thaw cycles.

Calculator

  • Reconstitution Calculator
  • Recombinant Protein Dilution Calculator
  • Specific Activity Calculator

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Related Tags: TRAIL R2/DR5/TNFRSF10B Protein, Human, Recombinant chemical structure | TRAIL R2/DR5/TNFRSF10B Protein, Human, Recombinant molecular weight